語言

Highlighting the Highlights

A-IMBN2010Several GRC research papers published in 2010 and reported on the A-IMBN website were further included in the “Research Highlights Collection 2010”. The complete version of this collection is available from the A-IMBN website

Listed under the Cell Biology category, an article “Following new instructions” mentioned how a cellular protein can switch off genes and thus promote lung cancer growth. This study was led by Dr. Li-Jung Juan. See original article posted in October 2010 in: http://www.natureasia.com/A-IMBN/article.php?id=406.

Under the Immunology & Therapeutics category, the article “Fighting the flu virus” described how the GRC team utilized the ultra high-throughput System and screened over 1.2 million chemicals to identify unique compounds that can prevent the influenza virus from reproducing. The team is led by Dr. Chi-Huey Wong, Dr. Yih-Shyun E. Cheng, Dr. Ting-Jen R. Cheng, Dr. Ying-Ta Wu, and Dr. Wei-Chieh Cheng, See original article posted on 15 December 2010 in: http://www.natureasia.com/A-IMBN/article.php?id=438.

In the article “Building a better booster” in the same category, it reported a modified version of the α-GalCer adjuvants that proved to be an added-plus when administered with vaccines for auto-immune diseases. The research was done by Dr. Chi-Huey Wong in collaboration with Dr. David Ho from US. See original article posted on 20 October 2010 in: http://www.natureasia.com/A-IMBN/article.php?id=407.

Seminars & Events

目前暫無活動

LATEST NEWS

  • The Next Chapter of Precision Chemical Modification: From Natural Product Inspirations to Efficient Drugs for Rare Disease +

    Read More
  • Sulfated Disaccharides Repair Toxic Protein Gain-of-Function, a New Approach to Treatment of Amyotrophic Lateral Sclerosis +

    Read More
  • Unveiling the Mystery of Cancer-Causing KRAS Gene Driving Pancreatic Precancerous Lesions +

    Read More
  • Unveiling Antigen Presentation and Cross-reactive Antibody Response of an Oligosaccharide-conjugate Vaccine, Paving the Way for Advanced Cancer Vaccines +

    Read More
  • Inhibition of SARS-CoV-2-mediated thromboinflammation by CLEC2.Fc +

    Read More
  • 1
  • 2